2023
DOI: 10.1016/j.ejro.2023.100503
|View full text |Cite
|
Sign up to set email alerts
|

Gadolinium contrast agents- challenges and opportunities of a multidisciplinary approach: Literature review

Nebal Iyad,
Muntaser S.Ahmad,
Sanaa G. Alkhatib
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 57 publications
(19 citation statements)
references
References 75 publications
0
19
0
Order By: Relevance
“…Where T (1⁄2 b) is the biological half-life for 131 I in the human body which equals to 6.3 day as the previous study shows [26][27][28][29][30][31][32][33]., and T1/2p is the physical half-life for 131 I which is 8.04 day. Table 2 displays the correlation coefficient R between the dependent variable (Activity) and the independent variable (beta at 1m), which is equal to (0.723), as well as the square of the correlation coefficient (R square), which is (0.523), which shows the percentage of variation between the two coefficients (moderate dependently), and the ANOVA table, which displays the value of (0.00), indicating a strong relationship between the variable's Activity and beta.…”
Section: Resultsmentioning
confidence: 99%
“…Where T (1⁄2 b) is the biological half-life for 131 I in the human body which equals to 6.3 day as the previous study shows [26][27][28][29][30][31][32][33]., and T1/2p is the physical half-life for 131 I which is 8.04 day. Table 2 displays the correlation coefficient R between the dependent variable (Activity) and the independent variable (beta at 1m), which is equal to (0.723), as well as the square of the correlation coefficient (R square), which is (0.523), which shows the percentage of variation between the two coefficients (moderate dependently), and the ANOVA table, which displays the value of (0.00), indicating a strong relationship between the variable's Activity and beta.…”
Section: Resultsmentioning
confidence: 99%
“…MRI contrast agents are typically used to enhance the contrast of certain tissues or blood vessels . However, small molecular contrast agents have a short half-life in the body, lasting only a few minutes, which makes them unsuitable for long-term, repetitive imaging . Although contrast agents based on polymers or nanoparticles have longer circulation times in the body, they tend to accumulate in organs such as the liver and kidneys after long-term circulation, leading to particularly high MRI signals in these organs.…”
Section: Molecular Imagingmentioning
confidence: 99%
“…Therefore, it is crucial to design contrast agents that have stronger contrast and minimal side effects. [97][98][99] Recently, biological nanomaterials have contributed to the development of medical imaging technology. Nanomolecular contrast agents exhibit excellent magnetization, longer cycle times, and fewer toxic side effects and have become a hot research topic today.…”
Section: Wide Application Of Ultrahigh Field Cmrmentioning
confidence: 99%